Predicting Cognitive Decline in Multiple Sclerosis: Implications for Clinical Trial Design

被引：0
|
作者：
Rao, Stephen M.
Lee, Jar-Chi
Strober, Lauren
Simon, Jack
Fisher, Elizabeth
Rudick, Richard
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A164 / A164
页数：1
相关论文
共 50 条
  • [41] Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis
    Motyl, Jiri
    Friedova, Lucie
    Vaneckova, Manuela
    Krasensky, Jan
    Lorincz, Balazs
    Blahova Dusankova, Jana
    Andelova, Michaela
    Fuchs, Tom A.
    Kubala Havrdova, Eva
    Benedict, Ralph H. B.
    Horakova, Dana
    Uher, Tomas
    DIAGNOSTICS, 2021, 11 (03)
  • [42] A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?
    Marina Katsari
    Dimitrios S. Kasselimis
    Erasmia Giogkaraki
    Marianthi Breza
    Maria-Eleftheria Evangelopoulos
    Maria Anagnostouli
    Elisabeth Andreadou
    Costas Kilidireas
    Alia Hotary
    Ioannis Zalonis
    Georgios Koutsis
    Constantin Potagas
    Journal of Neurology, 2020, 267 : 1464 - 1475
  • [43] Brain microstructural changes associated with cognitive decline in multiple sclerosis
    Abramovitz, A.
    Miron, S.
    Levy, O.
    Assaf, Y.
    Achiron, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S384 - S384
  • [44] Neurologists' accuracy in predicting cognitive impairment in multiple sclerosis
    Romero, Kristoffer
    Shammi, Prathiba
    Feinstein, Anthony
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2015, 4 (04) : 291 - 295
  • [45] Predicting cognitive decline
    Petersen, RC
    Ivnik, RJ
    O'Brien, PC
    Jack, CR
    Tangalos, E
    Boeve, BF
    Kokmen, E
    NEUROLOGY, 2000, 54 (07) : A231 - A231
  • [46] The changing face of multiple sclerosis clinical trial populations: Implications for ongoing and future clinical studies
    Uitdehaag, Bernard
    Barkhof, Fred
    Chang, Peter
    Coyle, Patricia K.
    Jeffery, Douglas
    Mikol, Daniel
    Schwid, Steven
    Stubinski, Bettina
    NEUROLOGY, 2008, 70 (11) : A89 - A89
  • [47] A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design
    Haacke, Ewart Mark
    Bernitsas, Evanthia
    Subramanian, Karthik
    Utriainen, David
    Palutla, Vinay Kumar
    Yerramsetty, Kiran
    Kumar, Prashanth
    Sethi, Sean K.
    Chen, Yongsheng
    Latif, Zahid
    Jella, Pavan
    Gharabaghi, Sara
    Wang, Ying
    Zhang, Xiaomeng
    Comley, Robert A.
    Beaver, John
    Luo, Yanping
    DIAGNOSTICS, 2022, 12 (01)
  • [48] IMPLICATIONS OF TREATMENT EMPOWERMENT IN PREDICTING ADHERENCE IN MULTIPLE SCLEROSIS
    Tuck, Chloe
    Lycett, Helen
    Raebel, Eva
    Guitart, Jordi
    Halai, Manjula
    Kenny, Tom
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S563 - S563
  • [49] Predicting neurocognitive decline in patients with multiple sclerosis using demographic variables
    Davis, Andrew S.
    Williams, Ronald
    Gupta, Ajay
    Berry, Kent
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1408 - 1408
  • [50] Preventing cognitive decline in older African Americans with mild cognitive impairment: Design and methods of a randomized clinical trial
    Rovner, Barry W.
    Casten, Robin J.
    Hegel, Mark T.
    Leiby, Benjamin E.
    CONTEMPORARY CLINICAL TRIALS, 2012, 33 (04) : 712 - 720
12345